“The Drug of Choice,” The Deal Pipeline
August 13, 2010
Adam H. Golden and Joel I. Greenberg authored the article “The Drug of Choice,” which appeared on The Deal Pipeline on August 13, 2010. The article discusses the emerging trend of single-product-driven M&A deals, in which pharmaceutical companies target a specific drug or development program, and outlines recent notable transactions. It also details some of the reasons that companies may choose these transactions and the risks that are involved.